Establishment Labs Holdings ( (ESTA) ) has released its Q4 earnings. Here is a breakdown of the information Establishment Labs Holdings presented to its investors.
Establishment Labs Holdings Inc. is a global medical technology company focused on enhancing women’s health and wellness, primarily in the breast aesthetics and reconstruction sector, known for its innovative solutions and extensive reach across over 90 countries.
In its latest earnings report, Establishment Labs announced its financial results for the fourth quarter and full year of 2024, highlighting a significant milestone with the U.S. launch of its Motiva Implants, which contributed to a notable increase in revenue. The company also reaffirmed its optimistic guidance for 2025, indicating strong growth prospects.
Key financial metrics from the report include a fourth-quarter revenue of $44.5 million, a substantial increase from the previous year, driven by the successful U.S. launch of Motiva Implants, which generated $3.3 million in revenue. The company also reported a reduction in net loss from operations to $18.7 million, a 15% improvement from the prior year, and an adjusted EBITDA loss of $13.1 million, marking a 25% improvement. Establishment Labs maintained a robust cash position with $90.3 million on hand, bolstered by an additional credit facility.
Looking forward, Establishment Labs is poised for continued growth, with 2025 revenue guidance set between $205 million and $210 million, reflecting a 23% to 26% increase over 2024. The company anticipates further expansion in the U.S. market and ongoing international sales growth, supported by its innovative product offerings and strategic initiatives.
The management of Establishment Labs remains confident in achieving its financial targets for 2025, driven by the momentum from its U.S. market entry and continued investment in innovation. The company is strategically positioned to capitalize on its technological advancements and expand its leadership in the global breast aesthetics and reconstruction markets.